Thirty-five generic drugmakers around the world will make cheap versions of Pfizer's highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer countries, the UN-backed Medicines Patent Pool said on Thursday .
Pfizer and Merck both struck deals with MPP to allow generic versions of their new drugs in some parts of the world, a rarity for pharmaceutical companies that usually fiercely protect their treatments over the life of their patents. The 35 companies that will produce versions of Paxlovid or its active ingredient are based in 12 different countries, the MPP said. They include some of the world's largest generic manufacturers like Israel's Teva Pharmaceutical Industries , India-based Sun Pharmaceutical Industries, and US-based Viatris Inc.
Pfizer will not receive royalties from the sale of the generic versions of its drug while COVID-19 remains classified as a"Public Health Emergency of International Concern" by the World Health Organization.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer seeks US FDA authorisation for fourth Covid-19 vaccine shot for seniors
Source: STForeignDesk - 🏆 4. / 71 Read more »
Pfizer-BioNTech seek US OK for second COVID-19 booster for 65 and olderPfizer and its German partner BioNTech SE on Tuesday (Mar 15) filed an application with US regulators seeking emergency use authorisation for a second booster shot of their COVID-19 vaccine for people aged 65 and older. The submission to the US Food and Drug Administration includes data collected Over two years and still considered “EUA” with no clear solution? What emergency? lol. A very convenient excuse to keep it going & potentially making it into a racketeering fraud. Esp when the vaccine is failing badly and designed for Alpha strain not Omicron.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Pfizer-BioNTech seek US approval of second COVID-19 booster for those aged 65 and olderPfizer and BioNTech announced Tuesday (Mar 15) they had formally asked the United States drug regulator for emergency approval of a second booster shot of their COVID-19 vaccine for people aged 65 and older. The companies said in a press statement that their request is based off two Israeli st
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Japan set to remove most Covid-19 restrictions as new infections ebb
Source: STForeignDesk - 🏆 4. / 71 Read more »
US Congress in impasse over new Covid-19 relief aid
Source: STForeignDesk - 🏆 4. / 71 Read more »
Japan set to remove most Covid-19 restrictions as new infections ebbTOKYO (REUTERS) - Japan is set to announce on Wednesday (March 16) the lifting of Covid-19 restrictions imposed on Tokyo and other prefectures as a wave of infections caused by the Omicron variant continues to ebb. Prime Minister Fumio Kishida is scheduled to speak at 10am...
Source: thenewpaper - 🏆 7. / 63 Read more »